Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,332,817 papers from all fields of science
Search
Sign In
Create Free Account
Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126
Known as:
EZH2 Inhibitor GSK2816126
, GSK2816126
A small molecule selective and S-adenosyl methionine (SAM) competitive inhibitor of histone-lysine N-methyltransferase EZH2, with potential…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
EZH2-activating mutation: no reliable indicator for efficacy of methyltransferase inhibitors
H. Quentmeier
,
C. Pommerenke
,
V. Hauer
,
C. Uphoff
,
M. Zaborski
,
H. Drexler
Leukemia and Lymphoma
2020
Corpus ID: 220796299
Abstract EZH2 gain of function mutations (EZH2GOFmu) has been implicated in the pathogenesis of B-non-Hodgkin lymphoma. The EZH2…
Expand
2020
2020
Abstract OI: Novel non-canonical functions of EZH2 in triple negative breast cancer
C. Kleer
2020
Corpus ID: 214457057
Patients with distant metastasis at the time of diagnosis have significantly worse prognosis. Triple negative breast carcinomas…
Expand
2017
2017
DUAL INHIBITION OF EZH2 AND HDAC IS SYNERGISTIC IN EZH2 DYSREGULATED LYMPHOMAS
J. Lue
,
S. Prabhu
,
Y. Liu
,
A. Verma
,
O. Elemento
,
J. Amengual
2017
Corpus ID: 80286001
rubicin, epirubicin, vinblastine, etoposide, paclitaxel, and topotecan. RTI‐79's PK characteristics are similar to rifabutin and…
Expand
2016
2016
Abstract 4481: Phosphorylation regulates EZH2 neoplastic functions in triple-negative breast cancer
T. Anwar
,
Caroline Arellano-Garcia
,
Boris Burman
,
C. Kleer
2016
Corpus ID: 88745002
Background: Triple negative (estrogen receptor, progesterone receptor, HER2-neu negative) breast cancers (TNBC) comprise 15% of…
Expand
2016
2016
NKTL. When investigating coimmunoprecipitates, they observed an association of both proteins. Pharmacologic inhibition of the JAK/STAT5 signaling pathway led to an increased H3K27 trimethylation…
2016
Corpus ID: 207760052
coimmunoprecipitates, they observed an association of both proteins. Pharmacologic inhibition of the JAK/STAT5 signaling pathway…
Expand
2014
2014
Replikacija DNA u sekundarnom limfnom tkivu
Vanja Tadić
2014
Corpus ID: 186025007
Germinativni centri (GC) folikula sekundarnog limfnog tkiva iznimno su dinamican okolis gdje B‐limfociti prolaze klonalnu…
Expand
2013
2013
Functional Defects In Neutrophils Derived From Ezh2 Null Mice
B. Caughey
,
Huafeng Xie
,
S. Orkin
,
D. Sykes
,
B. Ebert
,
R. Bejar
2013
Corpus ID: 208449798
Introduction We investigate the role of Ezh2 in neutrophil function using murine progenitor cells differentiated into neutrophils…
Expand
2013
2013
EZH2 T416 Phosphorylation Enhances Breast Cancer Tumorigenesis
A. Labaff
2013
Corpus ID: 81329455
2010
2010
EZH2 inhibitors在lapatinib處理之HER2low/neg乳癌細胞抑制轉移作用之探討
林家潔
2010
Corpus ID: 74199806
Breast cancer is a very common cancer around the world and overexpression of HER2 is found in 20-25% of the patients. HER2 is a…
Expand
2007
2007
PRDM 5 Identified as a Target of Epigenetic Silencing in Colorectal and Gastric Cancer
Yoshiyuki Watanabe
,
MinoruToyota
,
+12 authors
T. Tokino
2007
Corpus ID: 2908171
Purpose: PR (PRDI-BF1and RIZ) domain proteins (PRDM) are a subfamily of the kruppel-like zinc finger gene products that play key…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE